Skip to main content
logo
Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
4.800
+0.160 (3.45%)
May 29, 2026, 4:00 PM EDT - Market closed

MRVI Revenue by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Nucleic Acid Production
119.79M127.09M155.58M182.98M200.24M217.17M214.55M209.33M
Nucleic Acid Production Growth
-40.18%-41.48%-27.49%-12.59%-10.91%-38.87%-55.20%-67.84%
Biologics Safety Testing
65.96M65.35M64.25M62.86M62.92M63.58M64.03M64.77M
Biologics Safety Testing Growth
4.83%2.79%0.34%-2.95%-1.96%-1.10%-1.53%-3.13%

Adjusted EBITDA by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Biologics Safety Testing
44.24M43.61M44.00M42.59M43.84M45.90M46.22M47.09M
Biologics Safety Testing Growth
0.91%-4.98%-4.80%-9.56%-6.54%-1.33%-4.25%-9.54%
Nucleic Acid Production
-23.15M-20.12M3.25M31.83M50.81M70.85M71.98M64.87M
Nucleic Acid Production Growth
---95.48%-50.94%-38.53%-63.50%-76.88%-86.58%

Revenue by Geography

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
North America
112.38M111.65M121.31M122.99M127.09M132.08M131.91M133.92M
North America Growth
-11.58%-15.47%-8.03%-8.16%-9.90%-24.52%-44.62%-54.30%
EMEA
41.47M30.92M30.42M39.57M42.06M50.53M50.69M50.30M
EMEA Growth
-1.38%-38.81%-40.00%-21.33%-15.76%-61.36%-75.27%-83.56%
APAC
30.92M48.96M63.54M78.80M89.38M93.60M95.30M89.21M
APAC Growth
-65.40%-47.69%-33.33%-11.67%-8.27%-17.24%-4.65%-24.38%
Latin and Central America
971.00K757.00K586.00K501.00K662.00K706.00K686.00K681.00K
Latin and Central America Growth
46.68%7.22%-14.58%-26.43%25.62%8.78%-14.04%-19.60%
Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.